WO2005097672A3 - Procede de production de nanotubes en carbone remplis en partie par voie ferromagnetique, qui portent des biomolecules, et leur utilisation en matiere de diagnostic et de therapie - Google Patents

Procede de production de nanotubes en carbone remplis en partie par voie ferromagnetique, qui portent des biomolecules, et leur utilisation en matiere de diagnostic et de therapie Download PDF

Info

Publication number
WO2005097672A3
WO2005097672A3 PCT/EP2005/003790 EP2005003790W WO2005097672A3 WO 2005097672 A3 WO2005097672 A3 WO 2005097672A3 EP 2005003790 W EP2005003790 W EP 2005003790W WO 2005097672 A3 WO2005097672 A3 WO 2005097672A3
Authority
WO
WIPO (PCT)
Prior art keywords
carbon nanotubes
diagnosis
therapy
production
tube
Prior art date
Application number
PCT/EP2005/003790
Other languages
German (de)
English (en)
Other versions
WO2005097672A2 (fr
Inventor
Jens Ingolf Moench
Axel Meye
Albrecht Leonhardt
Gerd Hammermann
Manfred P Wirth
Bernd Buechner
Kai Kraemer
Original Assignee
Chung Dresden Leibniz Inst Fue
Univ Dresden Tech
Hamstein Consult Gmbh
Jens Ingolf Moench
Axel Meye
Albrecht Leonhardt
Gerd Hammermann
Manfred P Wirth
Bernd Buechner
Kai Kraemer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chung Dresden Leibniz Inst Fue, Univ Dresden Tech, Hamstein Consult Gmbh, Jens Ingolf Moench, Axel Meye, Albrecht Leonhardt, Gerd Hammermann, Manfred P Wirth, Bernd Buechner, Kai Kraemer filed Critical Chung Dresden Leibniz Inst Fue
Priority to EP05731324A priority Critical patent/EP1747018A2/fr
Publication of WO2005097672A2 publication Critical patent/WO2005097672A2/fr
Publication of WO2005097672A3 publication Critical patent/WO2005097672A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1268—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules host-guest, closed hollow molecules, inclusion complexes, e.g. with cyclodextrins, clathrates, cavitates, fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0097—Micromachined devices; Microelectromechanical systems [MEMS]; Devices obtained by lithographic treatment of silicon; Devices comprising chips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting

Abstract

L'invention concerne un procédé permettant de produire des nanotubes en matière plastique à une ou à plusieurs parois, remplis en partie par voie ferromagnétique (nanotubes en carbone (CNT)), qui sont remplis de fer, de cobalt, de nickel ou d'un alliage desdits éléments ou d'un alliage de ces éléments avec du platine et portent des biomolécules. Les biomolécules sont enfermées dans les tubes et/ou sont associées à la surface extérieure desdits tubes. Dans un mode de réalisation préféré, les nanotubes selon l'invention peuvent contenir deux principes actifs ou davantage dans les tubes, lesdits principes actifs étant libérés successivement lorsqu'ils sont utilisés dans le corps. L'invention concerne également l'utilisation des nanotubes en carbone selon l'invention, remplis en partie par voie ferromagnétique, dans le cadre de diagnostics et de thérapies, en particulier pour diagnostiquer et traiter des tumeurs.
PCT/EP2005/003790 2004-04-07 2005-04-07 Procede de production de nanotubes en carbone remplis en partie par voie ferromagnetique, qui portent des biomolecules, et leur utilisation en matiere de diagnostic et de therapie WO2005097672A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05731324A EP1747018A2 (fr) 2004-04-07 2005-04-07 Procede de production de nanotubes en carbone remplis en partie par voie ferromagnetique, qui portent des biomolecules, et leur utilisation en matiere de diagnostic et de therapie

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004017705A DE102004017705A1 (de) 2004-04-07 2004-04-07 Ferromagnetische Kohlenstoff-Nanoröhren, die Biomoleküle tragen, Verfahren zu deren Herstellung und deren Verwendung in Diagnose und Therapie
DE102004017705.8 2004-04-07

Publications (2)

Publication Number Publication Date
WO2005097672A2 WO2005097672A2 (fr) 2005-10-20
WO2005097672A3 true WO2005097672A3 (fr) 2006-05-18

Family

ID=35070427

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/003790 WO2005097672A2 (fr) 2004-04-07 2005-04-07 Procede de production de nanotubes en carbone remplis en partie par voie ferromagnetique, qui portent des biomolecules, et leur utilisation en matiere de diagnostic et de therapie

Country Status (3)

Country Link
EP (1) EP1747018A2 (fr)
DE (1) DE102004017705A1 (fr)
WO (1) WO2005097672A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993346B2 (en) 2009-08-07 2015-03-31 Nanomix, Inc. Magnetic carbon nanotube based biodetection
US9103775B2 (en) 2002-01-16 2015-08-11 Nanomix, Inc. Nano-electronic sensors for chemical and biological analytes, including capacitance and bio-membrane devices
US9291613B2 (en) 2002-06-21 2016-03-22 Nanomix, Inc. Sensor having a thin-film inhibition layer

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005005704B4 (de) * 2005-02-03 2010-08-12 Leibniz-Institut Für Festkörper- Und Werkstoffforschung Dresden E.V. Verwendung von Partikeln für die Ermittlung der lokalen Temperatur in organischen und nichtorganischen Körpern
ATE524197T1 (de) * 2006-05-25 2011-09-15 Univ Wake Forest Health Sciences Hyperthermische techniken und ihre therapeutische anwendung
US8501233B2 (en) 2007-03-13 2013-08-06 Wake Forest University Compositions and methods for treating cancer
US8784866B2 (en) 2007-03-26 2014-07-22 William Marsh Rice University Water-soluble carbon nanotube compositions for drug delivery and medicinal applications
WO2008118960A2 (fr) * 2007-03-26 2008-10-02 William Marsh Rice University Protection contre les rayonnements à l'aide de dérivés de nanotubes de carbone
WO2009070380A2 (fr) * 2007-10-03 2009-06-04 William Marsh Rice University Compositions de nanotubes de carbone solubles dans l'eau pour l'administration d'un médicament et applications médicales
CN102000349B (zh) * 2010-10-27 2013-11-27 上海师范大学 一种碳纳米管/聚合物/磁性铁酸盐纳米复合材料及其制备方法
CN102134732B (zh) * 2010-12-21 2013-03-06 北京化工大学 一种析氢模板法制备镍及镍基合金一维超结构纳米功能材料的方法
CN114522242B (zh) * 2022-02-28 2023-02-03 深圳大学 磁驱螺旋微纳米马达及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057359A2 (fr) * 2002-01-07 2003-07-17 The University Of Reading Microparticules et leurs procedes de production
WO2003068185A2 (fr) * 2002-02-14 2003-08-21 C Sixty, Inc. Utilisation de nanotubes de fullerene ou de carbone pour l'administration de medicaments
WO2004037316A2 (fr) * 2002-10-21 2004-05-06 University Of Florida Systeme de distribution de nanoparticules
WO2004089819A1 (fr) * 2003-04-14 2004-10-21 Centre National De La Recherche Scientifique Nanotubes de carbone fonctionnalises, procede de preparation et utilisation en chimie medicinale
CN1546365A (zh) * 2003-12-04 2004-11-17 东南大学 磁性纳米管及其制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057359A2 (fr) * 2002-01-07 2003-07-17 The University Of Reading Microparticules et leurs procedes de production
WO2003068185A2 (fr) * 2002-02-14 2003-08-21 C Sixty, Inc. Utilisation de nanotubes de fullerene ou de carbone pour l'administration de medicaments
WO2004037316A2 (fr) * 2002-10-21 2004-05-06 University Of Florida Systeme de distribution de nanoparticules
WO2004089819A1 (fr) * 2003-04-14 2004-10-21 Centre National De La Recherche Scientifique Nanotubes de carbone fonctionnalises, procede de preparation et utilisation en chimie medicinale
CN1546365A (zh) * 2003-12-04 2004-11-17 东南大学 磁性纳米管及其制备方法

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
A.R. HARUTYUNYAN ET AL: "CARBON NANOTUBES FOR MEDICAL APPLICATIONS", EUROPEAN CELLS & MATERIALS, vol. 3, no. Supplement 2, May 2002 (2002-05-01), & 4TH INTERNATIONAL CONFERENCE ON THE SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS.; TALLAHASSEE, FL, USA; MAY 09-11, 2002, pages 84 - 87, XP002365698, ISSN: 1473-2262 *
BRADBURY J: "Beyond pills and jabs", THE LANCET, vol. 362, no. 9400, 13 December 2003 (2003-12-13), pages 1984 - 1985, XP004783807, ISSN: 0140-6736 *
DATABASE WPI Section PQ Week 200521, Derwent World Patents Index; Class Q68, AN 2005-196908, XP002365721 *
J. JOHNSON ET AL: "THE MTC TECHNOLOGY: A PLATFORM TECHNOLOGY FOR THE SITE-SPECIFIC DELIVERY OF PHARMACEUTICAL AGENTS", EUROPEAN CELLS & MATERIALS, vol. 3, no. Supplement 2, May 2002 (2002-05-01), & 4TH INTERNATIONAL CONFERENCE ON THE SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS.; TALLAHASSEE, FL, USA; MAY 09-11, 2002, pages 12 - 15, XP002365701, ISSN: 1473-2262 *
J.F. YU ET AL.: "Radiolabeling of magnetic targeted carriers with several therapeutic and imaging radioisotopes", EUROPEAN CELLS & MATERIALS, vol. 3, no. Supplement 2, May 2002 (2002-05-01), & 4TH INTERNATIONAL CONFERENCE ON THE SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS.; TALLAHASSEE, FL, USA; MAY 09-11, 2002, pages 16 - 18, XP002365700, ISSN: 1473-2262 *
JEONG GOO-HWAN ET AL: "Formation and structural observation of cesium encapsulated single-walled carbon nanotubes.", CHEMICAL COMMUNICATIONS, no. 1, 7 January 2003 (2003-01-07), pages 152 - 153, XP002365703, ISSN: 1359-7345 *
PARK S J ET AL: "Synthesis and magnetic studies of uniform iron nanorods and nanospheres", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 122, 2000, pages 8581 - 8582, XP002306168, ISSN: 0002-7863 *
SATISHKUMAR B C ET AL: "Filling single-wall carbon nanotubes with d- and f-metal chloride and metal nanowires.", JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY. 2003 FEB-APR, vol. 3, no. 1-2, February 2003 (2003-02-01), pages 159 - 163, XP008059320, ISSN: 1533-4880 *
SON S J ET AL: "Magnetic nanotubes for magnetic-field-assisted bioseparation, biointeraction, and drug delivery", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 127, no. 20, 25 May 2005 (2005-05-25), pages 7316 - 7317, XP002365704, ISSN: 0002-7863 *
YANG CHIH-KAI ET AL: "Magnetism of transition-metal/carbon-nanotube hybrid structures.", PHYSICAL REVIEW LETTERS. 27 JUN 2003, vol. 90, no. 25 Pt 1, 27 June 2003 (2003-06-27), pages 257203, XP002365702, ISSN: 0031-9007 *
ZHENG MING ET AL: "DNA-assisted dispersion and separation of carbon nanotubes.", NATURE MATERIALS, vol. 2, no. 5, May 2003 (2003-05-01), pages 338 - 342, XP002365699, ISSN: 1476-1122 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9103775B2 (en) 2002-01-16 2015-08-11 Nanomix, Inc. Nano-electronic sensors for chemical and biological analytes, including capacitance and bio-membrane devices
US9291613B2 (en) 2002-06-21 2016-03-22 Nanomix, Inc. Sensor having a thin-film inhibition layer
US8993346B2 (en) 2009-08-07 2015-03-31 Nanomix, Inc. Magnetic carbon nanotube based biodetection

Also Published As

Publication number Publication date
EP1747018A2 (fr) 2007-01-31
WO2005097672A2 (fr) 2005-10-20
DE102004017705A1 (de) 2005-11-03

Similar Documents

Publication Publication Date Title
WO2005097672A3 (fr) Procede de production de nanotubes en carbone remplis en partie par voie ferromagnetique, qui portent des biomolecules, et leur utilisation en matiere de diagnostic et de therapie
Cai et al. Programmable nano–bio interfaces for functional biointegrated devices
Rauti et al. Properties and behavior of carbon nanomaterials when interfacing neuronal cells: How far have we come?
WO2006017333A3 (fr) Nanotubes de carbone raccourcis
Yin et al. Design, synthesis, and characterization of graphene–nanoparticle hybrid materials for bioapplications
Wujcik et al. Nanotechnology for implantable sensors: carbon nanotubes and graphene in medicine
Nezakati et al. Toxicology of chemically modified graphene-based materials for medical application
AU2003224070A8 (en) Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry
WO2006004599A3 (fr) Procedes de preparation de nanotubes de carbone monofeuillets
EP1637499A4 (fr) Nanoparticule metallique comportant un support, corps continu de nanoparticule metallique et procedes de production associe
WO2010057082A3 (fr) Capsules diagnostiques, systèmes de distribution/extraction, kits et procédés
WO2007012061A3 (fr) Prevention et traitement d'une maladie synucleinopathique et amyloidogenique
WO2006042260A3 (fr) Catheters a ballonnet renforces a elution de medicaments et procedes de fabrication
EP1810950A4 (fr) Agrégat de nanotube de carbone et procédé de fabrication idoine
WO2006020581A3 (fr) Prevention et traitement de maladies synucleinopathique et amyloidogenique
AU2003223807A8 (en) Method and apparatus for producing single-wall carbon nanotubes
EP1706911A4 (fr) Electrode en nanotubes de carbone ou en nanofibres de carbone comprenant des particules de soufre ou de metal utilisees en tant que liant et procede de fabrication correspondant
AU2003211943A1 (en) Process for producing single-walled carbon nanotube, single-walled carbon nanotube, and composition containing single-walled carbon nanotube
EP2486924A3 (fr) Médicaments et utilisations
EP1830381A3 (fr) Procédé destiné à la fabrication d'un élément de refroidissement, tout comme élément de refroidissement
Bagheri et al. Carbon nanomaterials as emerging nanotherapeutic platforms to tackle the rising tide of cancer–A review
Singh et al. Carbon nanotube as an emerging theranostic tool for oncology
WO2007139936A3 (fr) Technologies hyperthermiques et utilisations thérapeutiques associées
Aljerf et al. Carbon nanotubes-synthesis developmental engineering demands will overcome the health challenge of nanotoxicity and its acute mortality for humans
Ghoshal et al. Drug loading and release from functionalized multiwalled carbon nanotubes loaded with 6-mercaptopurine using incipient wetness impregnation method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005731324

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005731324

Country of ref document: EP